Unhappy with the preventive medication you’re on?
QR Code Link to This Post
If so, you may qualify for a research study that provides 12 months of study treatment with an approved CGRP antibody. The study treatment is being compared with regular care and all medications are paid for. No insurance is necessary and, in addition, we provide compensation for time and travel for each of the monthly visits the study requires.
You may qualify for the study, if you meet the following requirements:
• Older than 18 years of age (no upper age limit!)
• Migraine with less than 15 headache days per month
• Currently on a preventive migraine medication
• Never been treated with a CGRP antibody
For more information, please contact us at MedVadis Research in Watertown: 617-744-1310 or through our website: www.MedVadis.com. Your participation is voluntary.